Stepan (NYSE:SCL – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
Stepan Trading Up 2.3 %
NYSE:SCL traded up $1.41 during trading hours on Thursday, reaching $63.94. 113,269 shares of the company were exchanged, compared to its average volume of 124,893. Stepan has a 52-week low of $59.55 and a 52-week high of $94.76. The stock has a 50 day simple moving average of $64.21 and a 200 day simple moving average of $71.39. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of 31.81 and a beta of 0.84. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.27 and a quick ratio of 0.86.
Stepan (NYSE:SCL – Get Free Report) last issued its earnings results on Wednesday, February 19th. The basic materials company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.33). The firm had revenue of $525.60 million during the quarter, compared to analyst estimates of $520.97 million. Stepan had a net margin of 2.10% and a return on equity of 4.56%. Stepan’s revenue was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.33 EPS. As a group, analysts predict that Stepan will post 2.43 EPS for the current year.
Hedge Funds Weigh In On Stepan
About Stepan
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients.
Featured Stories
- Five stocks we like better than Stepan
- Best Aerospace Stocks Investing
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Top Stocks Investing in 5G Technology
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- The 3 Best Blue-Chip Stocks to Buy Now
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.